The Journal of Experimental Medicine
R&D Systems
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 20 August 2001. doi:10.1084/jem.194.4.541
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blazar, B. R.
Right arrow Articles by Taylor, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blazar, B. R.
Right arrow Articles by Taylor, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/8/541/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 4, August 20, 2001 541-550


Brief Definitive Report

CD47 (Integrin-associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells

Bruce R. Blazara, Frederik P. Lindbergc, Elizabeth Ingullib, Angela Panoskaltsis-Mortaria, Per-Arne Oldenborgc, Koho Iizukad, Wayne M. Yokoyamad, and Patricia A. Taylora
a University of Minnesota Cancer Center and Department of Pediatrics, Division of Bone Marrow Transplantation
b Nephrology Division, Minneapolis, MN 55455
c University of Washington School of Medicine, Department of Medicine, Infectious Diseases Division, Seattle, WA 98195
d Rheumatology Division and Howard Hughes Medical Institute, St. Louis, MO 63110

Correspondence to: Bruce R. Blazar, MMC 109, University of Minnesota Hospital, 420 SE Delaware St., Minneapolis, MN 55416. Tel:612-626-2734 Fax:612-624-3913 E-mail:blaza001{at}tc.umn.edu.

Integrin-associated protein (CD47) is a broadly expressed protein that costimulates T cells, facilitates leukocyte migration, and inhibits macrophage scavenger function. To determine the role of CD47 in regulating alloresponses, CD47+/+ or CD47-/- T cells were infused into irradiated or nonconditioned major histocompatibility complex disparate recipients. Graft-versus-host disease lethality was markedly reduced with CD47-/- T cells. Donor CD47-/- T cells failed to engraft in immunodeficient allogeneic recipients. CD47-/- marrow was unable to reconstitute heavily irradiated allogeneic or congenic immune–deficient CD47+/+ recipients. These data suggested that CD47-/- T cells and marrow cells were cleared by the innate immune system. To address this hypothesis, dye-labeled CD47-/- and CD47+/+ lymphocytes or marrow cells were infused in vivo and clearance was followed. Dye-labeled CD47-/- cells were engulfed by splenic dendritic cells and macrophages resulting in the clearance of virtually all CD47-/- lymphohematopoietic cells within 1 day after infusion. Host phagocyte-depleted CD47+/+ recipients partially accepted allogeneic CD47-/- T cells. Thus, dendritic cells and macrophages clear lymphohematopoietic cells that have downregulated CD47 density. CD47 expression may be a critical indicator for determining whether lymphohematopoietic cells will survive or be cleared.

Key Words: transplantation, in vivo animal models, T cells, stem cells, immune tolerance


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS